← Leaderboards
David R Deyle
University Of Washington
$2,826,042
Attributed
$2,938,428
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $597.4K · FY2008–20$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,938,428 · 4
By mechanism
R01$1,817,550 · 1
K08$657,605 · 1
R03$238,500 · 1
R43$224,773 · 1
Top collaborators
- Adrienne Leigh Watson1 shared
Most similar at University Of Washington
Same institution · by research overlap
- David R. Eyre$13,512,175
- Russell J Fernandes$3,138,382
- William G Couser$1,514,551
- Gregory Joseph King$589,416
- Peter H. Byers$1,792,915
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadIn VivoMutantMutationOsteogenesis ImperfectaGene TherapyCessation Of LifeCol1a2 GeneStem CellsMediatingProductionVectorCell TypeProteinsEffective TherapyKeratinocyteModificationBoneCellsDependovirusAdeno-Associated Viral VectorGene TargetingEmbryonic Stem CellFracture
Grant awards (16)
In Vivo Gene Targeting to Treat Inherited Bone Disease$349,800
R01 · FY2020 · AR · contact PI
In Vivo Gene Targeting to Treat Inherited Bone Disease$372,650
R01 · FY2019 · AR · contact PI
Development and Characterization of a Preclinical Swine Model of Osteogenesis Imperfecta$224,773
R43 · FY2019 · DE
In Vivo Gene Targeting to Treat Inherited Bone Disease$349,800
R01 · FY2018 · AR · contact PI
In Vivo Gene Targeting to Treat Inherited Bone Disease$45,700
R01 · FY2018 · AR · contact PI
In Vivo Gene Targeting to Treat Inherited Bone Disease$349,800
R01 · FY2017 · AR · contact PI
Engineering Pluripotent Stem Cells to Treat Osteogenesis Imperfecta$79,500
R03 · FY2016 · AR · contact PI
In Vivo Gene Targeting to Treat Inherited Bone Disease$349,800
R01 · FY2015 · AR · contact PI
Engineering Pluripotent Stem Cells to Treat Osteogenesis Imperfecta$79,500
R03 · FY2015 · AR · contact PI
Engineering Pluripotent Stem Cells to Treat Osteogenesis Imperfecta$79,500
R03 · FY2014 · AR · contact PI
Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta$121,635
K08 · FY2012 · AR · contact PI
Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta$122,338
K08 · FY2011 · AR · contact PI
Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta$121,764
K08 · FY2010 · AR · contact PI
Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta$121,205
K08 · FY2009 · AR · contact PI
Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta$50,000
K08 · FY2009 · AR · contact PI
Gene targeting with AAV vectors for the treatment of Osteogenesis Imperfecta$120,663
K08 · FY2008 · AR · contact PI